Abraham Chesed bought TTRX once, on Oct 23, 2025
Board Observer at Turn Therapeutics Inc.
SEC CIK 0002094374 · Filings on SEC.gov ↗
Abraham Chesed's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
1 filing since Oct 2025, newest first
About Abraham Chesed
Abraham (Avi) Chesed is an investor and entrepreneur known for his aptitude in building and structuring brands.( He serves as Board Observer at Turn Therapeutics Inc. (TTRX), where he has recently engaged in insider trading activity, including purchasing 14,286 common shares on October 23, 2025, at $4.60 per share, increasing his ownership to 1,447,268 shares,( and additional acquisitions reported on October 29, 2025.( His estimated net worth is at least $7 million as of January 6, 2026.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.